Estimation of ALU Repetitive Elements in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast Cancer.
Madhumathy G NairRakesh S RameshChandrakala M NaiduApoorva D MavatkarSnijesh V PVishakha RamamurthyVidya M SomashekaraiahAnupama C EKiruthiga RaghunathanAnuradha PanigrahiManjula DasSujan K DharJyothi S PrabhuPublished in: Cancers (2023)
Our results confirm the utility of cfDNA as an evolving liquid biopsy tool for molecular analysis. Evaluation of larger fragments of cfDNA estimated through ALU 247 can provide vital information concurrent with the pathological process of disease evolution in breast cancer and warrants expansion to other cancer types.